Seminars in Nephrology
Volume 31, Issue 6 , Pages 495-502 , November 2011

Diuretics in the Treatment of Hypertension

  • Michael E. Ernst, PharmD

      Affiliations

    • Department of Pharmacy Practice and Science, College of Pharmacy, and Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA
    • Corresponding Author InformationAddress reprint requests to Michael E. Ernst, PharmD, Department of Family Medicine, 01291-A/PFP, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242
    • ,
  • Samuel J. Mann, MD

      Affiliations

    • Department of Medicine, Division of Nephrology and Hypertension, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY

References 

  1. Grollman A, Harrison TR, Mason MF, Baxter J, Crampton J, Reichsman F. Sodium restriction in the diet for hypertension. JAMA. 1945;129:533–537
  2. Novello FC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J Am Chem Soc. 1957;79:2028–2029
  3. Moser M, Macauley AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am J Cardiol. 1959;3:214–219
  4. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009;361:2153–2164
  5. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment (A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research). Hypertension. 2008;51:1403–1419
  6. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005;18:619–626
  7. Beermann B, Groschinsky-Grind M. Clinical pharmacokinetics of diuretics. Clin Pharmacokinet. 1980;5:221–245
  8. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure?. J Ren Angio Aldo Sys. 2004;5:155–160
  9. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16:925–930
  10. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481–487
  11. Mach RS, Veyrat R. Clinical experiences with some of the newer diuretics, especially chlorthalidone. Ann N Y Acad Sci. 1960;88:841–863
  12. Kakaviotos N, Finnerty FA. Comparison of chlorthalidone, a long-acting antihypertensive and diuretic agent, with chlorothiazide. Am J Cardiol. 1962;10:570–574
  13. McLeod PJ, Ogilvie RI, Ruedy J. Effects of large and small doses of hydrochlorothiazide in hypertensive patients. Clin Pharmacol Ther. 1970;11:733–739
  14. Bengtsson C, Johnsson G, Sannerstedt R, Werko L. Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. BMJ. 1975;1:197–199
  15. Carney S, Gillies AI, Morgan T. Optimal dose of a thiazide diuretic. Med J Aust. 1976;2:692–693
  16. Materson BJ, Oster JR, Michael UF, Boltonn SM, Burton ZC, Stambaugh JE, et al. Dose response to chlorthalidone in patients with mild hypertension (Efficacy of a lower dose). Clin Pharmacol Ther. 1978;24:192–198
  17. Cushman WC, Khatri I, Materson BJ, Reda DJ, Freis ED, Goldstein G, et al. Treatment of hypertension in the elderly (III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents). Arch Intern Med. 1991;151:1954–1960
  18. Taler SJ, Textor SC, Augustine JE. Resistant hypertension (Comparing hemodynamic management to specialist care). Hypertension. 2002;39:982–988
  19. Gums JG, Lopez LM, Quay GP, Stein GH, McCarley DL. Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension. Drug Intell Clin Pharm. 1988;22:680–684
  20. Johnson JA, Gong Y, Bailey KR, Cooper-DeHoff RM, Chapman AB, Turner ST, et al. Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order. Clin Pharmacol Ther. 2009;86:533–539
  21. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009;3:CD001841
  22. Turnbull F Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527–1535
  23. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  24. Wright JT, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, et al. ALLHAT Collaborative Research Group ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med. 2009;169:832–842
  25. Wright JT, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, et al. ALLHAT Collaborative Research Group Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome. Arch Intern Med. 2008;168:207–217
  26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  27. National Collaborating Centre for Chronic Conditions. Hypertension: management in adults in primary care: pharmacological update. London: Royal College of Physicians; 2006;
  28. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751–1762
  29. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. ACCOMPLISH trial investigators Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–2428
  30. Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich). 2009;11:5–10
  31. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:4–9
  32. Ernst ME, Carter BL, Zheng S, Grimm RH. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23:440–446
  33. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352–358
  34. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial (Risk factor changes and mortality results). JAMA. 1982;248:1465–1477
  35. Bartsch G, Broste S, Grandits G, Grimm RH, Neaton JD, Svendsen KH. Hydrochlorothiazide, chlorthalidone and mortality in the Multiple Risk Factor Intervention Trial. Circulation. 1984;70(Suppl II):1438
  36. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10½ years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616–1628
  37. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583–592
  38. Sica DA. Chlorthalidone (Has it always been the best thiazide-type diuretic?). Hypertension. 2006;47:321–322
  39. Elliott WJ, Grimm RH. Using diuretics in practice—one opinion. J Clin Hypertens (Greenwich). 2008;10:856–862
  40. Taler SJ. Should chlorthalidone be the diuretic of choice for antihypertensive therapy?. Curr Hypertens Rep. 2008;10:293–297
  41. Kaplan NM. The choice of thiazide diuretics: why chlorthalidone may replace hydrochlorothiazide. Hypertension. 2009;54:951–953
  42. Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. J Clin Hypertens. 2010;12:927–934
  43. Kurtz TW. Chlorthalidone: don't call it “thiazide-like” anymore. Hypertension. 2010;56:335–337
  44. Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56:463–470
  45. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: sulfonamide diuretics revisited—old leads for new applications?. Org Biomol Chem. 2008;6:2499–2506
  46. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol. 1995;26:394–400
  47. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant. 2005;20:349–353
  48. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, et al. ALLHAT Collaborative Research Group Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic. Arch Intern Med. 2005;165:936–946
  49. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, et al. ALLHAT Collaborative Research Group Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med. 2006;144:172–180
  50. Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A. Torasemide, a new potent diuretic (Double-blind comparison with furosemide). Eur J Clin Pharmacol. 1986;31(Suppl):29–34
  51. Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis. 2008;51:199–211
  52. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009;3:CD007004
  53. Ellison DH. Diuretic resistance: physiology and therapeutics. Sem Nephrol. 1999;19:581–597
  54. Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med. 1981;141:1015–1019
  55. Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice (Part II: electrolyte and acid-base disorders complicating diuretic therapy). Expert Opin Drug Saf. 2010;9:259–273
  56. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the elderly program. Arch Intern Med. 1998;158:741–751
  57. Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, et al. ALLHAT Collaborative Research Group Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment (A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)). Arch Intern Med. 2006;166:2191–2201
  58. Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006;33:1341–1345
  59. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349:1628–1635

PII: S0270-9295(11)00133-1

doi: 10.1016/j.semnephrol.2011.09.004

Seminars in Nephrology
Volume 31, Issue 6 , Pages 495-502 , November 2011

Article Tools

* Image Usage & Resolution